\(
\def\WIPO{World Intellectual Property Organisation}
\)
Biotech patents : equivalence and exclusions under European and U.S. patent law / Li Westerlund.
2002
G 252 WES.B
Available at WIPO Library
Items
Details
Title
Biotech patents : equivalence and exclusions under European and U.S. patent law / Li Westerlund.
Description
x, 351 pages ; 25 cm
ISBN
9041188835
9789041188830 alk. paper
9789041188830 alk. paper
Alternate Call Number
G 252 WES.B
Summary
This book discusses patent legal issues regarding inventions in the field of biotechnology. The scope of a patent is of central concern, and since biotechnology is very different from other technologies, the requirements for disclosure and infringement are in focus. Eligibility issues are touched upon, although from more of an explanatory perspective, since the law is settled in this respect. The material for the analyses includes the European practices under the EPC, those of the United Kingdom, Germany, and the US. The mandated exclusions from patentability under the European patent laws of categories of plant and animal subject matter and certain biological processes are also analysed. Claim interpretation is the common theme. The challenge has been to present a comprehensive basis for grasping the substantive law for the field of biotechnology. The book examines thoroughly the differences between practices, and the consequences of those differences for the possibility of being granted a patent for an invention, and the infringement doctrines' effects for what might be called a patent's 'after-life', i.e. the scope of its protection.
Formatted Contents Note
1. Introduction
1.1. Patents to Life Forms
1.2. International and Regional Legal Instruments
1.3. Eligibility
1.4. Incentive to Invent
1.5. Complex Legal Situation
1.6. Proper Balance
1.7. Scope of Study
2. Invention or Discovery
2.1. Invention
2.2. Broadened Concept
2.3. Analysis
2.4. Patentability Problems
2.5. Concluding Remarks
3. Disclosure
3.1. Functions of Disclosure
3.2. The EPC
3.3. U.S. Patent Law
3.4. Concluding Remarks on Disclosure
4. Protection
4.1. Literal Infringement-British Law
4.2. German Law
4.3. The U.S. Practice
4.4. Remarks
5. Equivalency
5.1. British Practice
5.2. German Practice
5.3. European Harmonisation
5.4. U.S. Practice
5.5. Summarising Remarks
6. Exclusions from Patentability
6.1. The Purpose
6.2. The Concept of 'Plant Variety'
6.3. Analysis
6.4. The Concept of Animal Variety
6.5. Other Ways to Protect Varieties (Excurs) US Law.
1.1. Patents to Life Forms
1.2. International and Regional Legal Instruments
1.3. Eligibility
1.4. Incentive to Invent
1.5. Complex Legal Situation
1.6. Proper Balance
1.7. Scope of Study
2. Invention or Discovery
2.1. Invention
2.2. Broadened Concept
2.3. Analysis
2.4. Patentability Problems
2.5. Concluding Remarks
3. Disclosure
3.1. Functions of Disclosure
3.2. The EPC
3.3. U.S. Patent Law
3.4. Concluding Remarks on Disclosure
4. Protection
4.1. Literal Infringement-British Law
4.2. German Law
4.3. The U.S. Practice
4.4. Remarks
5. Equivalency
5.1. British Practice
5.2. German Practice
5.3. European Harmonisation
5.4. U.S. Practice
5.5. Summarising Remarks
6. Exclusions from Patentability
6.1. The Purpose
6.2. The Concept of 'Plant Variety'
6.3. Analysis
6.4. The Concept of Animal Variety
6.5. Other Ways to Protect Varieties (Excurs) US Law.
Series
Published
The Hague : Kluwer Law International, c2002.
Language
English
Record Appears in
all